These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3928980)

  • 1. The effects of sodium butyrate on lymphokine production.
    Le Gros GS; Herbert AG; Watson JD
    Lymphokine Res; 1985; 4(3):221-7. PubMed ID: 3928980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line.
    Lee JC; Hapel AJ; Ihle JN
    J Immunol; 1982 Jun; 128(6):2393-8. PubMed ID: 6122701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and biochemistry of T cell-derived lymphokines. I. The coordinate synthesis of interleukin 2 and colony-stimulating factors in a murine T cell lymphoma.
    Watson JD
    J Immunol; 1983 Jul; 131(1):293-7. PubMed ID: 6602832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium butyrate on growth and cell-cycle kinetics of cultured rabbit articular chondrocytes.
    Larno S; Ronot X; Adolphe M; Lechat P
    J Cell Physiol; 1984 Sep; 120(3):384-90. PubMed ID: 6205003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of differentiated subclones from a human salivary adenocarcinoma cell clone in culture after treatment with sodium butyrate.
    Azuma M; Hayashi Y; Yoshida H; Yanagawa T; Yura Y; Ueno A; Sato M
    Cancer Res; 1986 Feb; 46(2):770-7. PubMed ID: 3000585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate inhibits mouse fibroblasts at a control point in the G1 phase.
    Wintersberger E; Mudrak I; Wintersberger U
    J Cell Biochem; 1983; 21(3):239-47. PubMed ID: 6195168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IL-2 potentiates the IL-3 production by ConA activated mouse splenic T cells].
    Wu J; Wang ML; Qiu SL; Han JK; Zhu DX
    Shi Yan Sheng Wu Xue Bao; 1992 Mar; 25(1):25-30. PubMed ID: 1598800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A colony-stimulating factor for neutrophil granulocytes: a marked increase of its production by the addition of sodium butyrate and lipopolysaccharide in serum-free culture of RSP-2 X P3 cells.
    Tsuneoka K; Shikita M
    J Cell Physiol; 1985 Dec; 125(3):436-42. PubMed ID: 3877731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts.
    de Haan JB; Gevers W; Parker MI
    Cancer Res; 1986 Feb; 46(2):713-6. PubMed ID: 2416432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells.
    Weber TE; Kerr BJ
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):139-47. PubMed ID: 16725211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of cell growth-dependent gene transcript levels by sodium butyrate in serum stimulated fibroblasts.
    Aller P; Hirschhorn RR; Rius C
    Biochem Int; 1989 Jan; 18(1):119-27. PubMed ID: 2719709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
    Gillis S; Scheid M; Watson J
    J Immunol; 1980 Dec; 125(6):2570-8. PubMed ID: 6968790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
    Stoeck M; Northoff H; Resch K
    J Immunol; 1983 Sep; 131(3):1433-7. PubMed ID: 6604100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphokine production using IL-2-dependent human T-lymphocytes].
    Stecher A; Mohr H; Schügerl K
    Beitr Infusionther Klin Ernahr; 1987; 18():292-4. PubMed ID: 3125831
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of phorbol ester-mediated interleukin-2 production by cellular differentiating agents.
    Ravid A; Patya M; Rubin AL; Stenzel KH; Novogrodsky A
    Cancer Res; 1983 Nov; 43(11):5178-83. PubMed ID: 6604573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive production of interleukin 2 activity by a T cell hybridoma.
    Stull D; Gillis S
    J Immunol; 1981 May; 126(5):1680-3. PubMed ID: 6971310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-specific enhancement of type C virus activation by sodium n-butyrate.
    Long CW; Suk WA; Snead RM; Christensen WL
    Cancer Res; 1980 Nov; 40(11):3886-90. PubMed ID: 6258768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.